2006
DOI: 10.1111/j.1365-2036.2006.03090.x
|View full text |Cite
|
Sign up to set email alerts
|

The effects of tegaserod on oesophageal function and bolus transport in healthy volunteers: studies using concurrent high‐resolution manometry and videofluoroscopy

Abstract: SUMMARY BackgroundTegaserod is a partial 5-hydroxytryptamine 4 receptor agonist with prokinetic effects on the gastrointestinal tract, its effects on oesophageal function are unknown.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
70
2
1

Year Published

2007
2007
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(79 citation statements)
references
References 28 publications
6
70
2
1
Order By: Relevance
“…Furthermore, in ineffective swallows the site of bolus escape coincided with the position of the transition zone or pressure trough on manometry. In a subsequent study in healthy volunteers they showed that a 7-day course of the prokinetic tegaserod promoted mid-esophageal contractility and shortened the pressure transition zone, the level at which bolus escape occurred most frequently [25]. These are encouraging studies and suggest possible clinical usefulness of high-resolution manometry in identifying focal abnormalities of esophageal function that respond to specific management.…”
Section: Evaluation Of Dysphagiamentioning
confidence: 86%
“…Furthermore, in ineffective swallows the site of bolus escape coincided with the position of the transition zone or pressure trough on manometry. In a subsequent study in healthy volunteers they showed that a 7-day course of the prokinetic tegaserod promoted mid-esophageal contractility and shortened the pressure transition zone, the level at which bolus escape occurred most frequently [25]. These are encouraging studies and suggest possible clinical usefulness of high-resolution manometry in identifying focal abnormalities of esophageal function that respond to specific management.…”
Section: Evaluation Of Dysphagiamentioning
confidence: 86%
“…31 While conventional manometry did not establish the physiological basis of this effect, the use of HRM revealed that Tegaserod promoted midesophageal contractility and shortened the proximal transition zone. 32 Another preliminary study suggests that HRM may identify specific dysmotility patterns that respond to specific pharmacologic intervention. For example, symptomatic focal spasm was shown to respond to sildenafil.…”
Section: Effect Of Medicationsmentioning
confidence: 99%
“…22 Several studies have evaluated the effects of 5-HT 4 agonists on esophageal peristalsis and LES function in non-SSc patients, showing different results. [23][24][25][26][27] However, use of these agents is restricted due to cardiac safety profile issues. Another serotonin receptor agonist, namely the 5-HT1A receptor agonist sumatriptan, may enhance esophageal peristalsis after subcutaneous administration in healthy subjects.…”
Section: Discussionmentioning
confidence: 99%